Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 1
Review
Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,883 | Dovepress* | 7,883+ | 1,993 | 9,876 | |
Totals | 7,883 | 1,993 | 9,876 | ||
*Since 7 March 2008 +Since July 2016 |
View citations on Google Scholar